SCHEMBL9469326

SCHEMBL9469326

CCCCCCCCCCCCCC(=O)N1CCCCC1CNC(=O)CCCCCN

nearest known ligand 0.83

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.74
TP53 P04637 1/20 0.74
CYP1A2 P05177 1/20 0.74
CYP2D6 P10635 1/20 0.74
MAPT P10636 1/20 0.74
CYP2C9 P11712 1/20 0.74
CYP2C19 P33261 1/20 0.74
KMT2A Q03164 1/20 0.74
SLC6A5 Q9Y345 2/20 0.43
OPRD1 P41143 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9469217 0.94 MEN1 (0.69) MEN1TP53CYP1A2CYP2D6MAPT
SCHEMBL8582612 0.94 MEN1 (0.64) MEN1TP53CYP1A2CYP2D6MAPT
SCHEMBL9469445 0.91 MEN1 (0.67) MEN1TP53CYP1A2CYP2D6MAPT
Hydrochloric Acid SCHEMBL9469603 0.89 MEN1 (0.66) MEN1TP53CYP1A2CYP2D6MAPT
Fumaric Acid SCHEMBL9469589 0.88 MEN1 (0.62) MEN1TP53CYP1A2CYP2D6MAPT
Fumaric Acid SCHEMBL9469594 0.88 MEN1 (0.62) MEN1TP53CYP1A2CYP2D6MAPT
SCHEMBL9469488 0.88 MEN1 (0.70) MEN1TP53CYP1A2CYP2D6MAPT
SCHEMBL9469386 0.85 MEN1 (1.00) MEN1TP53CYP1A2CYP2D6MAPT
SCHEMBL9468961 0.85 MEN1 (1.00) MEN1TP53CYP1A2CYP2D6MAPT
SCHEMBL9469286 0.85 MEN1 (1.00) MEN1TP53CYP1A2CYP2D6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992003415-A1 PROTEIN KINASE C MODULATORS NOVA PHARMACEUTICAL CORPORATION (US) 1992-03-05 WO claimed
US-5189046-A Antiinflammatory agents, anticonvulsants NOVA PHARMACEUTICAL CORPORATION (US) 1993-02-23 US disclosed
WO-1992003415-A1 PROTEIN KINASE C MODULATORS NOVA PHARMACEUTICAL CORPORATION (US) 1992-03-05 WO disclosed